Liang Han

Liang Han

Auto-generated profile, based on publicly available information

Liang Han

School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2014 in Nature
Verified
Journal Article
Open access
PDF file
BMBenjamin D. McNeil
Benjamin D. McNeil
PPPriyanka Pundir
Priyanka Pundir
SMSonya Meeker
Sonya Meeker
LHLiang Han
Liang Han
BUBradley J. Undem
Bradley J. Undem
XDXinzhong Dong
Xinzhong Dong
Cationic substances, including some drugs, can activate mast cells in an IgE-independent manner, leading to histamine release, inflammation and airway contraction; here, the G-protein-coupled receptor MrgprB2, the orthologue of human MRGPRX2, is shown to be the sole mast cell receptor for these substances in mice. Mast cells, innate immune cells found in most tissues of the body and are active in allergic reactions. Mast cells can be activated in an immunoglobulin-E-independent manner by cationic substances such as pro-inflammatory signalling peptides, therapeutic drugs and components of animal toxins, leading to histamine release, inflammation and airway contraction. Xinzhong Dong and colleagues now show that a single G-protein-coupled receptor called Mrgprb2, the orthologue of human MRGPRX2, is the sole mast cell receptor for these substances in mice. This work identifies MRGPRX2 as a potential therapeutic target to counter a range of drug-induced adverse effects, and Mrgprb2 knockouts and other mice used in the study will provide a model in which to address the role of antibody-independent activation of mast cells in diseases with an allergic component. Mast cells are primary effectors in allergic reactions, and may have important roles in disease by secreting histamine and various inflammatory and immunomodulatory substances1,2. Although they are classically activated by immunoglobulin (Ig)E antibodies, a unique property of mast cells is their antibody-independent responsiveness to a range of cationic substances, collectively called basic secretagogues, including inflammatory peptides and drugs associated with allergic-type reactions1,3. The pathogenic roles of these substances have prompted a decades-long search for their receptor(s). Here we report that basic secretagogues activate mouse mast cells in vitro and in vivo through a single receptor, Mrgprb2, the orthologue of the human G-protein-coupled receptor MRGPRX2. Secretagogue-induced histamine release, inflammation and airway contraction are abolished in Mrgprb2-null mutant mice. Furthermore, we show that most classes of US Food and Drug Administration (FDA)-approved peptidergic drugs associated with allergic-type injection-site reactions also activate Mrgprb2 and MRGPRX2, and that injection-site inflammation is absent in mutant mice. Finally, we determine that Mrgprb2 and MRGPRX2 are targets of many small-molecule drugs associated with systemic pseudo-allergic, or anaphylactoid, reactions; we show that drug-induced symptoms of anaphylactoid responses are significantly reduced in knockout mice; and we identify a common chemical motif in several of these molecules that may help predict side effects of other compounds. These discoveries introduce a mouse model to study mast cell activation by basic secretagogues and identify MRGPRX2 as a potential therapeutic target to reduce a subset of drug-induced adverse effects.

23 December 2012 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
LHLiang Han
Liang Han
CMChao Ma
Chao Ma
QLQin Liu
Qin Liu
HWHao-Jui Weng
Hao-Jui Weng
YCYiyuan Cui
Yiyuan Cui
XDXinzhong Dong
Xinzhong Dong
Dorsal root ganglion neurons respond to both painful and itchy stimuli, but whether itch-specific neurons exist was, up until now, unknown. Here the authors describe a group of MrgprA3-expressing neurons that innervate the superficial layers of the skin and selectively sense itch. Itch-specific neurons have been sought for decades. The existence of such neurons has been doubted recently as a result of the observation that itch-mediating neurons also respond to painful stimuli. We genetically labeled and manipulated MrgprA3+ neurons in the dorsal root ganglion (DRG) and found that they exclusively innervated the epidermis of the skin and responded to multiple pruritogens. Ablation of MrgprA3+ neurons led to substantial reductions in scratching evoked by multiple pruritogens and occurring spontaneously under chronic itch conditions, whereas pain sensitivity remained intact. Notably, mice in which TRPV1 was exclusively expressed in MrgprA3+ neurons exhibited itch, but not pain, behavior in response to capsaicin. Although MrgprA3+ neurons were sensitive to noxious heat, activation of TRPV1 in these neurons by noxious heat did not alter pain behavior. These data suggest that MrgprA3 defines a specific subpopulation of DRG neurons mediating itch. Our study opens new avenues for studying itch and developing anti-pruritic therapies.

1 February 2014 in Neuron
Verified
Journal Article
Closed access
YKYu Shin Kim
Yu Shin Kim
YCYuxia Chu
Yuxia Chu
LHLiang Han
Liang Han
MLMan Li
Man Li
ZLZhe Li
Zhe Li
XDXinzhong Dong
Xinzhong Dong

17 October 2012 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
QLQin Liu
Qin Liu
PSParul Sikand
Parul Sikand
CMChao Ma
Chao Ma
ZTZongxiang Tang
Zongxiang Tang
LHLiang Han
Liang Han
XDXinzhong Dong
Xinzhong Dong
β-alanine, a popular supplement for muscle building, induces itch and tingling after consumption, but the underlying molecular and neural mechanisms are obscure. Here we show that, in mice, β-alanine elicited itch-associated behavior that requires MrgprD, a G-protein-coupled receptor expressed by a subpopulation of primary sensory neurons. These neurons exclusively innervate the skin, respond to β-alanine, heat, and mechanical noxious stimuli but do not respond to histamine. In humans, intradermally injected β-alanine induced itch but neither wheal nor flare, suggesting that the itch was not mediated by histamine. Thus, the primary sensory neurons responsive to β-alanine are likely part of a histamine-independent itch neural circuit and a target for treating clinical itch that is unrelieved by anti-histamines.

2 July 2007 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
ZWZhexing Wen
Zhexing Wen
LHLiang Han
Liang Han
JBJames R. Bamburg
James R. Bamburg
SSSangwoo Shim
Sangwoo Shim
GMGuo-li Ming
Guo-li Ming
JZJames Q. Zheng
James Q. Zheng
Bone morphogenic proteins (BMPs) are involved in axon pathfinding, but how they guide growth cones remains elusive. In this study, we report that a BMP7 gradient elicits bidirectional turning responses from nerve growth cones by acting through LIM kinase (LIMK) and Slingshot (SSH) phosphatase to regulate actin-depolymerizing factor (ADF)/cofilin-mediated actin dynamics. Xenopus laevis growth cones from 4–8-h cultured neurons are attracted to BMP7 gradients but become repelled by BMP7 after overnight culture. The attraction and repulsion are mediated by LIMK and SSH, respectively, which oppositely regulate the phosphorylation-dependent asymmetric activity of ADF/cofilin to control the actin dynamics and growth cone steering. The attraction to repulsion switching requires the expression of a transient receptor potential (TRP) channel TRPC1 and involves Ca2+ signaling through calcineurin phosphatase for SSH activation and growth cone repulsion. Together, we show that spatial regulation of ADF/cofilin activity controls the directional responses of the growth cone to BMP7, and Ca2+ influx through TRPC tilts the LIMK-SSH balance toward SSH-mediated repulsion.

6 May 2014 in Annual Review of Biophysics
Verified
Journal Article
Closed access
LHLiang Han
Liang Han
XDXinzhong Dong
Xinzhong Dong
The itch-scratch reflex serves as a protective mechanism in everyday life. However, chronic persistent itching can be devastating. Despite the clinical importance of the itch sensation, its mechanism remains elusive. In the past decade, substantial progress has been made to uncover the mystery of itching. Here, we review the molecules, cells, and circuits known to mediate the itch sensation, which, coupled with advances in understanding the pathophysiology of chronic itching conditions, will hopefully contribute to the development of new anti-itch therapies.